ETS1 is a member of the evolutionarily conserved family of ets genes, which are transcription factors that bind to unique DNA sequences, either alone or by association with other proteins. In this study, we have used the yeast two-hybrid system to identify an ETS1 interacting protein. The ETS1 N-terminal amino acid region was used as bait and an interaction was identi®ed with the Daxx protein, referred to as EAP1 (ETS1 Associated Protein 1)/Daxx. This interactin has been shown to exist in yeast and in vitro. EAP1/Daxx and ETS1 are colocalized in the nucleus of mammalian cells. The region in EAP1/Daxx which speci®cally binds to ETS1 is located within its carboxy terminal 173 amino acid region. The ETS1 interaction region is located within its N-terminal 139 amino acids and is referred as the Daxx Interaction Domain (DID). The DID appears to be conserved in several other ets family members, as well as in other proteins known to interact with Daxx. The EAP1/Daxx interacts with both isoforms of ETS1, p51-ETS1 and p42-ETS1. Interaction of EAP1/Daxx with ETS1 causes the repression of transcriptional activation of the MMP1 and BCL2 genes. The interaction domains of both ETS1 and EAP1/Daxx are required for this repression and deletion of either domain abolishes this activity. Oncogene (2000) 19, 745 ± 753.
Introduction
Ets proteins constitute a family of sequence speci®c DNA binding proteins, which share a highly conserved 85 amino acid residue DNA-binding domain (ETS domain) and function as transcription factors (Watson et al., 1988; Ho et al., 1990; Bhat and Papas, 1994; Bassuk and Leiden, 1997) . ETS proteins are found from C. elegans to human. Amino acid sequence alignment of 49 ETS genes has been used to construct a phylogenetic tree, allowing sub-classi®cation into nine groups, including PEA3, ETS, ERG, ERF, ELG, ELK, ELF, YAN and SPI (Lautenberger et al., 1992; Graves and Petersen, 1998) . ETS proteins carry out critical roles in many biological processes, involving development and function of the mammalian immune system (Bhat et al., 1989 Bassuk and Leiden, 1997) , dierentiation (Athanasiou et al., 1996) , oncogenesis (Seth et al., 1989; Seth and Papas, 1990; Watson et al., 1997; Ghysdael and Boureux, 1997) and embryonic development (Maroulakou et al., 1994; Barton et al., 1998) .
ETS1, the founding member of the ETS family, is one of the cellular genes forming the transforming protein of the E26 virus. ETS1 plays important roles in cell proliferation, dierentiation, lymphoid cells development, transformation, invasiveness, angiogenesis, and apoptosis (Bhat et al., 1996; Huang et al., 1997; Li et al., 1999) . ETS1 controls the expression of critical genes involved in these processes by binding to ets binding sites (EBS) present in the transcriptional regulatory regions. The mechanisms whereby individual ETS proteins regulate the expression of a unique set of target genes remains to be determined, but is likely to be controlled at multiple levels. Protein ± protein interactions provide one important mechanism to control the speci®city of target gene selection by ETS proteins. Transcriptional regulation is dependent upon the combinatorial interactions between multiple nuclear proteins. Unlike many other well-known families of transcription factors that can associate as homo-or heterodimers, Ets proteins are able to form complexes with other transcription factors. Such interactions may strengthen the transactivating activity and/or de®ne target gene speci®city. Many transcription factors have their DNA binding sites adjacent to ets binding sites (EBS) . Depending on the precise sequence context, binding of Ets protein near other transcription factors results in higher anity interactions, synergistic repression or activation of speci®c target genes. For example, the presence of both ETS1 and CBF proteins enhance the binding anity of both proteins for beta E2 (Halle et al., 1997; Wotton et al., 1994) . The basic and zipper region of MafB, an AP-1 like protein, interacts with the ets domain of ETS1 in a DNA-dependent manner and inhibits ETS1-mediated transactivation of the transferrin receptor, which is known to be essential for erythroid dierentiation (Sieweke et al., 1996) . Physical interaction of ETS1 with GHF-1 is required for establishing lactotrophspeci®c PRL gene expression . ETS1, as well as other family members, binds to the early B-cell-speci®c mb-1 promoter by using Pax-5 as a cell type-speci®c docking protein (Fitzsimmons et al., 1996) . AP-1 tethers ETS1 to the TIMP-1 promoter via protein ± protein interaction to achieve ETS-dependent transcriptional activation (Logan et al., 1996) .
To identify additional proteins that may modulate ETS1 function, we initiated a study to isolate proteins based upon their interaction with ETS1. The Nterminal 139 amino acids of human ETS1 was chosen as bait for a yeast two-hybrid interactive screen. In this report, we describe the identi®cation and characterization of a protein interacting with human ETS1, termed EAP1 (ETS1 associated protein-1)/Daxx. The interaction between ETS1 and EAP1/Daxx identi®ed in yeast occurs in vitro in the absence of DNA and EAP1/Daxx is co-localized with ETS1 in nucleus of mammalian cells. Signi®cantly, we ®nd that EAP1/Daxx is able to repress ETS1-dependent transactivation of MMP1 and BCL2 promoters. Collectively, the data suggest that EAP1/Daxx is able to bind to ETS1 in vivo and subsequently function as a transrepressor. We have also identi®ed two putative motifs located in the DID domain of ETS1 and other EAP1/Daxx interacting proteins required for protein ± protein interaction.
Results

Two hybrid system screen
We have used the yeast two-hybrid interaction trap method (Gyuris et al., 1993) to screen for proteins that interact with the ETS1 protein. Full-length ETS1 has been shown to possess transcriptional activity. In order to select an appropriate ETS1 protein bait, a series of lexA202-fused truncated ETS1 protein constructs were prepared. Protein expression was con®rmed by Western blot analysis utilizing a LexA antibody and the repression assay was used to verify the transport of the baits into the nucleus. As shown in Figure 1 , only the N139-ETS1 fragment derived from the N-terminal domain of ETS1 and the C362-ETS1 fragment derived from the C-terminal domain met the requirement as a bait. To screen for binding proteins, an EGY48 yeast strain that expresses the LexA-N139-ETS1 fusion protein was transformed with a fetal brain cDNA library. The cDNAs were fused to the B42 transactivation domain (Gyuris et al., 1993) . Of the approximately 1610 6 transformants, 35 colonies were capable of galactose-dependent growth on media lacking leucine and production of b-galactosidase. Plasmid DNA was isolated from positive yeast colonies and 23 individual clones were identi®ed by restriction mapping of PCR products. All clones were sequenced and eight of the 23 clones were found to be novel. Three overlapping clones (17, 27 and 30) were found to encode dierent parts of an identical protein. We have named this ETS1 interacting protein as EAP1 (ETS-1 Associated Protein-1). The protein encoded by these clones was subsequently identi®ed as the Daxx gene (Yang et al., 1997) . A schematic representation of the Daxx protein along with the clones interacting with the N139-ETS1 bait is shown in Figure 2A . Figure 2B shows the relative b-galactosidase activity generated by the interactions of the EAP1 clones and the bait N139-ETS1, with clone 27 exhibiting the highest activity. The speci®city of binding of Daxx clone 27 with ETS1 was con®rmed in yeast by measuring the relative bgalactosidase activity utilizing several baits (Table 1 ). The data show that only the N139 bait binds speci®cally to Daxx. It is also interesting to note that The relative galactosidase activity of the Lac-Z reporter was measured. This activity was controlled by the Lex-A operator. Plasmids pSH-17-4 and pRHMI were used as positive and negative controls, respectively. Yeast cells transformed with the indicated LexA-ETS1 fusion protein were grown in the presence of 2% galactose and 2% ra medium. Leucine auxotrophy was performed in the above yeast cells by plating them on Gal/CM-Ura, -His, -Leu dropout plates. Yeast clones were checked on day 3 (++) and up to day 6 (+). Repression was measured by using the reporter gene pJK101 and the LexA-ETS1 fusion constructs. Expression levels of fusion proteins were monitored by Western blotting analysis using the LexA antibody EAP1/Daxx represses ETS1 dependent transcription R Li et al only MafB, which is known to bind to ETS1 (Sieweke et al., 1996) , was also capable of interacting with clone 27.
Characterization of full-length EAP1/Daxx
The full-length EAP1/Daxx was cloned by PCR from human T lymphocyte Jurkat cell cDNA (Materials and methods). The sequence of EAP1/Daxx was deposited in the GenBank (Accession number: AF097742). Amino acid alignment between the mouse and human EAP1/Daxx showed 70% homology. In vitro translated EAP1/Daxx was found to migrate at a molecular weight of 120 kD, similar to what was previously reported (Kiriakidou et al., 1997) . We have found that EAP1/Daxx has nearly ubiquitous expression (data not shown) as previously described (Herberg et al., 1998; Kiriakidou et al., 1997; Yang et al., 1997) .
Interaction of ETS1 with EAP1/Daxx
We showed above that the 139 amino acid region from the amino terminus of the ETS1 protein interacts with the 173 amino acid region from the carboxyl terminus of EAP1/Daxx protein. 
Subcellular localization of the EAP1/Daxx protein
It is known that ETS1 is a transcription factor binding to a unique DNA sequence (-GGAA/T-), and is localized in the nucleus. To determine whether interactions exist between ETS1 and EAP1/Daxx in vivo, we determined the sub-cellular localization of EAP1/Daxx. We utilized the stably transfected DLD1-p51-ETS1 cell line expressing high levels of p51-ETS1. This cell line was transiently transfected with a FLAG-EAP1/Daxx construct. Detection of EAP1/Daxx was performed utilizing an antibody directed against FLAG. Thus, only the exogenously expressed EAP1/ Daxx protein was detected. The upper panel of Figure  4 shows that both ETS1 and EAP1/Daxx are localized in the nucleus (Figure 4a ,b) as de®ned by DNA nuclear staining ( Figure 4c ). Shown in the lower panel of Figure 4 (e ± h) is the parental DLD1 cell line, which does not express endogenous ETS1. The exogenously expressed FLAG-EAP1/Daxx is localized in the nucleus. We have identi®ed two putative nuclear localization signals from the predicted amino acid sequence, at position 397 ± 402 and 639 ± 646 amino acid, respectively. A polyclonal antibody against fulllength EAP1/Daxx protein was used to localize the endogenous EAP1/Daxx and the exogenously expressed Daxx protein. Both forms of EAP1/Daxx were detected in nucleus (data not shown). 
Repression of ETS1 dependent transcriptional activity by EAP1/Daxx
In order to identify the functional signi®cance of the interaction between EAP1/Daxx and ETS1, the eect of EAP1/Daxx on ETS1 dependent transcriptional activity was measured utilizing the luciferase reporter gene driven by MMP1 (Rutter et al., 1998), or BCL2 (Chen and Boxer, 1995) promoters. MMP1 has been shown to be a relevant target gene for ETS1 and is involved in the process of tumor invasion and metastasis (Iwasaka et al., 1996; Oda et al., 1999) . BCL2 gene is transcriptionally regulated by both p51-ETS1 and p42-ETS1 (R Li, unpublished data). Promoter constructs of MMP1 or BCL2 luciferase reporter were transiently co-transfected in COS-1 cells either with p51-ETS1 alone or with p51-ETS1 plus EAP1/Daxx ( Figure 5 ). p51-ETS1 increases the transcriptional activity of both MMP1 and BCL2. However EAP1/Daxx together with p51-ETS1 represses the transcriptional activity of both MMP1 and BCL2. The transcriptional activities of p51-ETS1 were inhibited by EAP1/Daxx up to 58% for MMP1, and 70% for BCL2, respectively. EAP1/Daxx protein has no signi®-cant eects on the basal activity of these reporter genes in COS-1 cells. Protein expression levels of both EAP1/ Daxx and p51-ETS1 were monitored by Western blotting (data not shown). To further characterize the mechanism of EAP1/Daxx repression of ETS1 transcriptional activity, we evaluated whether EAP1/Daxx directly aects the binding of ETS1 protein to DNA. Electrophoretic mobility shift assays (EMSA) were performed using oligonucleotides containing the EBS from the MMP1 promoter. The addition of EAP1/Daxx did not signi®cantly inhibit ETS1 binding (data not shown). Thus, it is likely that EAP1/DAxx represses ETS1 dependent transactivity by another mechanism.
EAP1/Daxx protein lacking the ETS1 interaction domain has no effect on ETS1 dependent transcriptional activity
We have demonstrated that the interaction domain between ETS1 and EAP1/Daxx is contained within the Figure 6A ). However, N567-EAP1/Daxx, which lacks the interaction domain does not repress this activity. These results indicate that the interaction domain is functionally important in repressing transcriptional activity. Essentially identical results were obtained utilizing the promoter of another functional target of ETS1, MMP1 ( Figure 6B ). These data strongly support the conclusion that the interaction domain of EAP1/Daxx plays a role in the transcriptional repression of at least two genes regulated by ETS1. It will be of interest to determine if EAP1/Daxx is also involved in repressing the activity of other ETS1 target genes.
EAP1/Daxx represses ETS1 dependent transcriptional activity in stable transfected DLD1 cell lines
To further study the role of EAP1/Daxx in repressing transcriptional activity, we have utilized stable transfectants, expressing EAP1/Daxx, p42-ETS1 and p51-ETS1 alone or combination. The results are similar to those previously shown utilizing transient transfection. The EAP1/Daxx expressing cell line did not activate (A) The BCL2 promoter construct with the luciferase reporter was co-transfected in COS-1 cells with p51-ETS1 alone, p51-ETS1 and N567-EAP1/Daxx (Del 567 ± 740aa), or p51-ETS1 N312-EAP1/Daxx (Del 1 ± 312aa). Similarly, the construct of BCL2 was also co-transfected with p42-ETS1 alone, p42-ETS1 and N567-EAP1/Daxx (Del 567 ± 740aa), or p42-ETS1 and N312-EAP1/Daxx (Del 1 ± 312aa). Total amounts of DNA were normalized by the addition of carrier vector pcDNA3.1. Luciferase activities were measured after 24 h of transfection. The values were normalized by b-galactosidase activity from a co-transfected CH110-Lac-Z vector. Assays were performed in triplicate and represented two independent experiments. (B) The MMP1 promoter construct with the luciferase reporter was co-transfected in COS-1 cells with p42-ETS1 alone, p42-ETS1 plus an increased amount of either N567-EAP1/Daxx (Del 567 ± 740aa), or with N312-EAP1/Daxx (Del 1 ± 312aa). Total amounts of DNA were normalized by the addition of carrier vector pcDNA3.1. Luciferase activities were measured after 24 h of transfection. The values were normalized by b-galactosidase activity from a co-transfected CH110-Lac-Z vector. Assays were performed in triplicate and represented two independent experiments EAP1/Daxx represses ETS1 dependent transcription R Li et al the MMP1 promoter, while this promoter was active in both the p51-ETS1 and p42-ETS1 expressing cell lines. A dramatic decrease in the transcriptional activity of the MMP1 gene was obtained in cell lines expressing both p51-ETS1 and EAP1/Daxx. ( Figure 7B , lanes 5 and 6).
Discussion
The ETS family of transcription factors is conserved throughout evolution. Family members are present in Drosophila and humans, indicating that the family has existed for more than 600 million years (Pribyl et al., 1998 (Pribyl et al., , 1991 Lautenberger et al., 1992) . They bind to unique DNA sequences, either by themselves or by forming complexes with partner proteins. ETS1 controls the expression of target genes that play critical roles in cell proliferation, dierentiation, lymphoid cell development, transformation, angiogenesis, and apoptosis (Bhat et al., 1996) . Sequence recognition can be in¯uenced by other factors in the vicinity of the EBS. Therefore, the geometry of the binding site and the adjacent factors will in¯uence the selection of target genes.
In this paper, we have utilized the yeast two-hybrid system to identify ETS1 interacting proteins. A 139 amino acid region of the amino terminus of the ETS1 protein was used as bait. This region includes the Pointed (PNT) domain and an adjacent mitogenactivated protein (MAP) kinase phosphorylation site. PNT is conserved in a subset of the ets family members. Nuclear magnetic resonance (NMR) spectroscopy analysis of this domain indicates that it forms an independent structure with unique architecture of a monomeric ®ve-helix bundle (Slupsky et al., 1998) . With this bait, we have identi®ed several putative interacting proteins. One of the clones was further characterized and found to be Daxx, which was originally reported to be involved in the Fas death pathway (Yang et al., 1997) .
The interaction region of EAP1/Daxx is located in the c-terminal 173 amino acids. This region was tested in the yeast system with several ETS1 baits ( Table 1 ). The only region that interacts with EAP1/Daxx is 139 amino acid from the amino terminus of ETS1. Thus, we have identi®ed the interaction domains of both ETS1 and EAP1/Daxx. EAP1 clone 30, which contains all the amino acids present in clone 27, is not as active as clone 27. This may be due to conformational dierences between the clone 27 and 30 proteins, such that the additional amino terminal amino acids of clone 30 protein interfere with its ability to bind ETS1. It became important to examine whether the native ETS1 and EAP1/Daxx protein interact. Our data demonstrates that EAP1/Daxx interacts with both p51-ETS1 and its spliced variant, p42-ETS1 in solution. The p42-ETS1 lacks exon VII, which encodes 87 amino acids directly adjacent to the DNA binding domain (Jorcyk et al., 1991) . Since the interaction domain is present in both ETS1 isoforms and both of these proteins interact with EAP1/Daxx, amino acids derived from exon VII do not contribute to the conformation of the Daxx interaction domain of ETS1 protein. This is consistent with the conclusion from structural studies that the N-terminal 139 amino acids of ETS1 protein forms an independent structure with unique architecture (Slupsky et al., 1998) . We have also observed that EAP1/Daxx binds to itself ( Figure 3B ,a, lane 4) and the signi®cance of this selfinteraction remains to be further evaluated.
That ETS1 and EAP1/Daxx are predicted to be localized in the nucleus, strongly suggests the possibility for a physiological interaction. We have tested this hypothesis by examining the subcellular localization of both ETS1 and EAP1/Daxx. Our results clearly demonstrate that ETS1 and EAP1/Daxx are colocalized in the nucleus supporting the suggestion of a possible interaction (Figure 4) . The functional importance of the interaction between ETS1 and EAP1/Daxx is clearly demonstrated. We have shown that this interaction leads to the transcriptional repression of two relevant ETS1 target genes MMP1 and BCL2. Removal of the ETS1 interacting domain from EAP1/Daxx results in the loss of transcriptional repression. The data in this paper are summarized diagramatically in Figure 8 , which shows the structure of the EAP1/Daxx gene. The domain that we have found to interact with ETS1 is designated the ETS1 Binding Domain. We also have identi®ed the region of ETS1 that binds to EAP1/Daxx, which we refer to as the Daxx Interaction Domain (DID). Ets family members are known to share many sequence homologies. The most widely conserved region within the gene family is the DNA binding domain of 85 amino acids, and its structure has been determined (Werner et al., 1995) . The DID overlaps with the previously described HLH (Seth and Papas, 1990) and PNT (Pointed) domains, which is the second most highly conserved domain. It became, therefore, of interest to determine if other ets family members have homologous sequences. Alignment of several ets family proteins demonstrates sequence homology in the putative DID of two other family members, ETS2 and FLI1. Greatest homology is found in two separate regions within the DID (DID motif I and II). This homology predicts that EAP1/ Daxx will bind to ETS2 and FLI1 and regulate their activity. This may lead to the coordinate regulation of the ets family which would also regulate the expression of their common target genes. We are presently investigating the interaction of EAP1/Daxx with other family members.
A search for the existence of DID motifs in other proteins known to bind to Daxx, including PAX3 (Hollenbach et al., 1999) and CENP-C (Pluta et al., 1998) was carried out. It is signi®cant that these motifs are conserved in both of these proteins. We, therefore, propose that the EAP1/Daxx protein may be a general regulatory molecule involved in the control of the activities of many nuclear proteins by binding to the DID motifs of those proteins. It has been shown that several ets proteins are phosphorylated in response to extracellular signals. The threonine 38 (T38) in ETS1 or threonine 72 in ETS2 are the only phosphorylation sites responding to these signals . It is interesting to note that the putative motif of DID in both ETS1 and ETS2 contain these phosphorylation sites. So that it is possible that the extracellular signal from ERK pathway aects the interaction of ETS1 with its partner such as EAP1/Daxx.
As mentioned above, H-Daxx has been previously identi®ed as a PAX3 interacting protein and represses PAX3 dependent transactivity (Hollenback et al., 1999) . PAX3 is a member of an evolutionarily conserved family of Pax genes. Similar to the ets family, Pax family members function as transcriptional regulators that control gene expression (Dahl et al., 1997) . It is likely that the biological signi®cance of EAP1/Daxx may be determined by its predominate interacting protein, which may be controlled during the cell cycle, developmental stage and the speci®c cell line.
The recent report on the Drosophila Groucho gene family describes the function of these proteins as non-DNA binding co-repressors for speci®c subsets of DNA binding transcription factors (Fisher and Caudy, 1998) . These proteins repress transcription via a conserved intrinsic repression domain. We have shown in this paper that the Daxx protein has many similarities to Groucho. For example, it also represses transcription of a subset of genes by interaction with a unique domain of DNA binding transcription factors. In addition, it has been shown previously that Daxx also binds to other transcription factors, repressing their activity (Hollenbach et al., 1999) and to an intrinsic centromeric protein which may have a regulatory role in mitosis (Pluta et al., 1998) .
Materials and methods
Two hybrid system
The interaction trap assay system and a human fetal brain cDNA library were kindly provided by Dr Roger Brent (Harvard Medical School, Boston, MA, USA). All experiments were performed in the yeast reporter strain EGY48 yeast cells [MATa leu2 7 his 7 trp 7 upa 7 LEU2 : : plexaop6LEU2(DUASLEU2)]. The yeast vector pEG202 is a LexA DNA-binding domain (1 ± 202aa) encoding vector that allows fusion of desired protein into its C-terminal part. A series of ETS1 bait constructs were inserted into pEG202 vector in frame of LexA. DNA fragments for these constructs were generated by PCR ampli®cation using Pfu polymerase (Stratagene, La Jolla, CA, USA) and primers designed with appropriate restriction sites. The human fetal brain cDNA library was constructed using the yeast vector pJG-45, which contains a B42 activation domain that allows fusion of desired protein to its C-terminus. Plasmid constructs were sequenced by the Taq Dideoxy Terminator Cycle sequencing method (Applied Biosystems, Foster City, CA, USA) using an Applied Biosystems model 373 automated sequencer. The library screen, b-galactosidase assays and general yeast manipulate were performed as described previously (Ausubel et al., 1995) .
Cloning and plasmid construct
For cloning of full-length EAP1/Daxx: proof reading PCR was used to amplify a 2158 bp fragment from human T lymphocyte Jurkat cell cDNA by the forward primer, 5'-ATCCCCTATGGCCACCGCTAACA-3' (Kiriakidou et al., 1997) and reverse primer, 5'-CACACTTGTCTTGCAAG-TACCAG-3' (derived from the sequence of our initial clone). The product was digested by EcoRI and NcoI and inserted into p2tk2/2700, which was constructed by inserting the 718 bp EcoRI/XhoI fragment of clone 27 into the p2tk2 vector. The plasmid generated above yields a GST fused fulllength EAP1/Daxx protein. pcDNA3.1-EAP1/Daxx were made by inserting a BamHI/XhoI fragment into pcDNA3.1 (Invitrogen, Carlsbad, CA, USA). Deletion constructs of N567-EAP1/Daxx (del 567 ± 740) and C312-Daxx (del 1 ± 312) were generated by inserting the PCR fragment containing the native start codon into appropriated cloning sites of pcDNA3.1 vector. The XhoI/HindIII fragment of pcDNA3.1-EAP1/Daxx was inserted into the SalI and HindIII sites of pFlag-cmv-2 vector to generate FLAG-EAP1/Daxx.
Indirect immune-staining
Cells were grown on glass 35 mm dish and ®xed in PBS containing 4% paraformaldehyde and 0.5% Triton X-100 for 30 min at room temperature. The cells were then washed twice with PBS, and nonspeci®c binding was blocked for 25 min with 3% bovine serum albumin and 10% fetal bovine serum in PBS. The cells were then incubated with anitypuri®ed Anti-¯ag M5 Mab (Eastman Kodak, New Haven, CT, USA) or anti-ETS1 polyclone (C-20 Santa Cruz, CA, USA) for 1 h at room temperature, and washed ®ve times with PBS, followed by incubation with Fluorescein conjugated anti mouse IgG (Pierce, Rockford, IL, USA) for FLAG and Rhodamine conjugated anti rabbit IgG (Pierce, Rockford, IL, USA) for recognized Ets1 C-20 polyclone (Santa Cruz, CA, USA) for 1 h, respectively. The cells were additionally washed four times with PbS containing 0.02% 4', 6-diamidino-2-phenylindole (DAPI) for staining of nucleus, and the coverslips were mounted with Gel/Mount aqueous mounting medium (Fisher, Pittsburgh, PA, USA) and observed using a¯uorescent microscope.
GST pull-down assays
Plasmid constructs of GST-EAP1/Daxx, GST-p51-ETS1 and GST-p42-ETS1 were generated in pGEX-2TK2 derived pGEX-2TK (Pharmacia-Biotech, Piscataway, NJ, USA) by inserting multiple-cloning sites. The fusion proteins were puri®ed as described in the manufacturer's protocol.
35
Slabeled protein were obtained by in vitro translation reactions (TNT coupled reticulocyte lysate system, Promega). Two micrograms of DNA were used in the presence of complete amino acid mix with T7 RNA Polymerase as per the manufacturer's protocol. GST fusion protein (2 ± 5 mg) was bound to glutathione-agarose beads and incubated with 35 Slabeled protein (5 ml), in 0.2 ml binding buer (20 mM HEPES pH 7.6, 3 mM MgCL 2 , 0.1 mM EDTA, 0.1% Tween-20, 10% Glycerol, 1 mM DTT, 0.2 M KCL, 2% BSA). The mixture was incubated by rocking for 2 h at 48C. The glutathione-agarose beads were washed four times in binding buer (without BSA), resuspended in 20 ml of SDS sample buer, and the proteins were released from the bead by boiling for 5 min. The proteins were analysed by 10% SDS ± PAGE and autoradiography.
Cell line and transfection
COS-1 and the human colon cancer DLD1 (human colon carcinoma cell, ATCC-CCL221) and DLD1 stable transfectants were used in these experiments. Transient transfections were carried out using Superfect (Qiagen, Valencia, CA, USA) as per the manufacturer's directions. For reporter assays, cells were seeded 24 h prior to transfection in 24-well plates. Equal amount of DNA was maintained in each transfection by addition of pcDNA3.1 vector. Cells were harvested 24 h after transfection and luciferase activity was measured by a luciferase assay kit (Promega). Preparation of cell lysates and reporter assays were done as per the manufacturer's protocols. Assay results were corrected for equal amount of protein. All transfections were performed at least three times in duplicate or triplicate. In addition, stable DLD1 transfectants expressing EAP1/Daxx and EAP1/Daxx plus either p51-ETS1 or p42-ETS1 were established and the clones were maintained in RPMI with 10% fetal bovine serum (FBS) in the presence of G418 (400 mg/ml). Western blots were developed by enhanced chemiluminescence (ECL). Anti-EAP1/Daxx polyclonal antibody was generated against full-length EAP1/Daxx generated from GST-EAP1/Daxx after thrombin cleavage. Antibody against ETS1 (c-20, sc350) was purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA).
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